Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeChristian Drosten, Hans Wilhelm Doerr, Stephan Günther et al.|New England Journal of Medicine|2003Cited by 4.8k
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Jindřich Činátl, Alexander F. Yakunin et al.|Nature Medicine|2016Cited by 185
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A. Armstrong, Yogesh Kulathu, Sven M. Lange et al.|PLoS ONE|2021Cited by 96
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Jindřich Činátl|Nature Communications|2019Cited by 82
Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading FrameMarijke van Rikxoort, Jindřich Činátl|PLoS ONE|2012Cited by 44